ATE99737T1 - Tgf-beta codierende nucleinsaeure und deren verwendungen. - Google Patents

Tgf-beta codierende nucleinsaeure und deren verwendungen.

Info

Publication number
ATE99737T1
ATE99737T1 AT86302112T AT86302112T ATE99737T1 AT E99737 T1 ATE99737 T1 AT E99737T1 AT 86302112 T AT86302112 T AT 86302112T AT 86302112 T AT86302112 T AT 86302112T AT E99737 T1 ATE99737 T1 AT E99737T1
Authority
AT
Austria
Prior art keywords
nucleic acid
tgf
beta
encoding nucleic
beta encoding
Prior art date
Application number
AT86302112T
Other languages
English (en)
Inventor
Rik Michel Andre Derynck
David Vannorman Goeddel
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE99737T1 publication Critical patent/ATE99737T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/495Transforming growth factor [TGF]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT86302112T 1985-03-22 1986-03-21 Tgf-beta codierende nucleinsaeure und deren verwendungen. ATE99737T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71514285A 1985-03-22 1985-03-22
EP86302112A EP0200341B1 (de) 1985-03-22 1986-03-21 TGF-beta codierende Nucleinsäure und deren Verwendungen

Publications (1)

Publication Number Publication Date
ATE99737T1 true ATE99737T1 (de) 1994-01-15

Family

ID=24872822

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86302112T ATE99737T1 (de) 1985-03-22 1986-03-21 Tgf-beta codierende nucleinsaeure und deren verwendungen.

Country Status (7)

Country Link
EP (1) EP0200341B1 (de)
JP (2) JPH0659230B2 (de)
AT (1) ATE99737T1 (de)
DE (1) DE3689495T2 (de)
DK (1) DK175412B1 (de)
IE (1) IE61119B1 (de)
IL (1) IL78197A (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989012101A1 (en) * 1988-06-08 1989-12-14 Genentech, Inc. NUCLEIC ACID ENCODING TGF-beta3 AND ITS USE
NZ222168A (en) * 1986-10-20 1991-05-28 Oncogene Science Inc Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions
US4931548A (en) * 1987-01-30 1990-06-05 Techne Corporation Heterodimer form of transforming growth factor-beta
AU1340688A (en) * 1987-01-30 1988-08-24 Techne Corporation Transforming growth factor-beta
AU1539188A (en) * 1987-05-04 1988-11-10 Bristol-Myers Squibb Company TGF-B2 and novel compositions having anti-neoplastic activity
JPS6463395A (en) * 1987-05-04 1989-03-09 Oncogen Oncostatin m and novel composition having antitumor activity
AU626524B2 (en) * 1987-05-29 1992-08-06 Bristol-Myers Squibb Company Cloning and expression of simian transforming growth factor- beta 1
US5221620A (en) * 1987-10-06 1993-06-22 Oncogen Cloning and expression of transforming growth factor β2
IL87877A0 (en) * 1987-10-06 1989-03-31 Oncogen Cloning and expression of transforming growth factor beta2
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
US5422340A (en) * 1989-09-01 1995-06-06 Ammann; Arthur J. TGF-βformulation for inducing bone growth
US5158934A (en) * 1989-09-01 1992-10-27 Genentech, Inc. Method of inducing bone growth using TGF-β
CA2070393A1 (en) * 1989-10-18 1991-04-19 Charles M. Cohen Biosynthetic constructs of tgf-beta
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
TW517059B (en) 1994-07-25 2003-01-11 Ciba Geigy Ag New process for the production of biologically active protein
DE69726870T2 (de) * 1996-07-29 2004-10-28 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Und Zum Vertrieb Von Pharmaka Mbh EGF-ähnlicher Faktor von Chromaffingranula und von Gliazellen stammender neurotropher Faktor mit überlebensfördernder Aktivität auf dopaminerge Neuronen
GB9822682D0 (en) * 1998-10-16 1998-12-09 Gemini Research Limited Diagnostic method and apparatus based on polymorphism in a TGF-B-Gene
JP2002539172A (ja) 1999-03-17 2002-11-19 ノバルティス アクチエンゲゼルシャフト Tgf−ベータを含む医薬組成物
US7211271B2 (en) 2001-03-12 2007-05-01 The Regents Of The University Of California Method to improve hydroxyapatite implantation and stimulate bone regeneration
CA2561686C (en) 2004-03-31 2014-12-02 Genentech, Inc. Humanized anti-tgf-beta antibodies
GB0604964D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Protein folding
GB0604966D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Medicaments and proteins
GB0604938D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Proteins, nucleic acids and medicaments
BRPI0716680A2 (pt) 2006-11-02 2013-09-24 Daniel J Capon "composto, multÍmero, composiÇço, mÉtodo de afetar a atividade de um alvo, complexo, processo de produÇço do composto, mÉtodo de produÇço de um extensço de aminoÁcidos consecutivos, processo de produÇço de uma extensço de aminoacidos consecutivos , processo para a produÇço de um composto , mÉtodo de produÇço de uma proteina e polipeptÍdeo"
WO2018203541A1 (ja) * 2017-05-02 2018-11-08 株式会社カネカ 免疫グロブリン結合活性を有するポリペプチドの回収精製法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0154434B1 (de) * 1984-02-17 1993-01-27 Genentech, Inc. Menschlicher Transformationswachstumsfaktor und Vorläufer oder Fragment hiervon, Zellen, DNA, Vektoren und Verfahren zu ihrer Herstellung, Zusammensetzungen und Produkte, die diese enthalten, sowie davon abgeleitete Antikörper und Diagnostizierverfahren

Also Published As

Publication number Publication date
IE860743L (en) 1986-09-22
IE61119B1 (en) 1994-10-05
DE3689495T2 (de) 1994-06-01
JPH0763378B2 (ja) 1995-07-12
JPS61219395A (ja) 1986-09-29
IL78197A (en) 1991-07-18
JPH06169777A (ja) 1994-06-21
EP0200341B1 (de) 1994-01-05
IL78197A0 (en) 1986-07-31
DK127786D0 (da) 1986-03-20
DK127786A (da) 1986-09-23
JPH0659230B2 (ja) 1994-08-10
DK175412B1 (da) 2004-09-27
EP0200341A1 (de) 1986-11-05
DE3689495D1 (de) 1994-02-17

Similar Documents

Publication Publication Date Title
DE3689495D1 (de) TGF-beta codierende Nucleinsäure und deren Verwendungen.
DE3650751D1 (de) Antikörper gegen Saugetier-Interleukin-4 und Peptide verwendbar als Antigenen für deren Herstellung
AU6329694A (en) Recombinant expression vectors and purification methods for thermus thermophilus DNA polymerase
FI871908A0 (fi) Transformering av trichoderma-moegel.
ES2072892T3 (es) Proteina receptora para un factor 2 estimulante de celulas b humanas.
DE69434067D1 (de) Menschliche neuronale nikotin-acetylcholin-rezeptor-verbindungen und methoden ihres einsatzes
DK460882A (da) Dna-sekvens, der koder for humant immun-interferon, replicerbareudtrykkelsesmedier herfor, mikroorganisme- eller cellekulturer transformeret med saadanne og fremgangsmaade til fremstilling af et polypeptid, der omfatter aminosyresekvensen af humant immun-interferon
DE69300158D1 (de) TGF-Beta induziertes Gen und Protein.
DK170186A (da) Biologisk ren kultur af en stamme lactobacillus acidophilus samt fremgangsmaade til isolering af en saadan kultur og anvendelse af denne somlaegemiddel
DE3684892D1 (de) Eukaryotische fusionsproteine, ihre herstellung und verwendung sowie mittel zur durchfuehrung des verfahrens.
DK0666914T3 (da) Hidtil ukendt P-selectin-ligandprotein
BR8205954A (pt) Sequencia de dna,plasmidio recombinante,cultura bacteriana e microorganismos
FI90436B (fi) Ihmisen gammainterferonin kaltaisesti vaikuttavien polypeptidien valmistus
DE3688671D1 (de) Menschliches interferon-beta2a vektoren, die gene enthalten, die fuer das genannte interferon kodieren zellinien, die dieses produzieren und verwendung des genannten interferons als pharmazeutikum.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
ZA857721B (en) Process for treatment of rheumatic diseases
IL85759A0 (en) The cloning of malaria-specific dna sequences,isolation of the gene for the 140 kd protein
ATE119206T1 (de) Dmd-sonden.
DE69119461D1 (de) Strukturgen von membrangebundenem Alkoholdehydrogenase-Komplex, Plasmid, das dieses Gen enthält und transformierte Essigsäurebakterien
LV5677A3 (lv) Bakteriju lactobacillus casei var. alactosus celms - L(+)-pienskabes producents izmantojams lopbaribas konservesanai
IT8719124A0 (it) Procedimento per l'introduzione di dna plasmidiale in ceppi batterici del genere lactobacillus e costruzione di vettori plasmidiali specifici.
DE3675670D1 (de) Mit furazanoxid modifizierter kautschuk und diesen enthaltende kautschukmischungen.
IT1204508B (it) Conversione microbica di antraciclinoni del corrispondente 13-(s)-diidro-13-o-beta-d-glucopiranoside

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time